Approval to extend the autodelfia hafp kit onto the delfia xpress instrument.  The modified version, namely, delfia xpress hafp kit is designed to be used with the 6000 delfia xpress clinical random access screening platform.  The device, as modified, will be marketed under the trade name delfia xpress hafp kit and is indicated for `the quantitative determination of human alpha-fetoprotein (afp) in maternal serum and amniotic fluid obtained between the 15th and 20th weeks of gestation.  The assay is to be performed on the 6000 delfia xpress clinical random access screening platform and is intended for use only in conjunction with other diagnostic tools such as ultrasound and amniography as an aid in the detection of open neural tube defects (ontds).